These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27942772)
1. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis. Fujimoto Y; Azuma YT; Matsuo Y; Kuwamura M; Kuramoto N; Miki M; Azuma N; Teramoto M; Nishiyama K; Izawa T; Nakajima H; Takeuchi T Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):261-268. PubMed ID: 27942772 [TBL] [Abstract][Full Text] [Related]
2. B cells that produce immunoglobulin E mediate colitis in BALB/c mice. Hoving JC; Kirstein F; Nieuwenhuizen NE; Fick LC; Hobeika E; Reth M; Brombacher F Gastroenterology; 2012 Jan; 142(1):96-108. PubMed ID: 21983080 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-19 protects mice from innate-mediated colonic inflammation. Azuma YT; Matsuo Y; Kuwamura M; Yancopoulos GD; Valenzuela DM; Murphy AJ; Nakajima H; Karow M; Takeuchi T Inflamm Bowel Dis; 2010 Jun; 16(6):1017-28. PubMed ID: 19834971 [TBL] [Abstract][Full Text] [Related]
5. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Nishida A; Lau CW; Zhang M; Andoh A; Shi HN; Mizoguchi E; Mizoguchi A Gastroenterology; 2012 Apr; 142(4):865-874.e2. PubMed ID: 22202458 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 19 reduces inflammation in chemically induced experimental colitis. Matsuo Y; Azuma YT; Kuwamura M; Kuramoto N; Nishiyama K; Yoshida N; Ikeda Y; Fujimoto Y; Nakajima H; Takeuchi T Int Immunopharmacol; 2015 Dec; 29(2):468-475. PubMed ID: 26476684 [TBL] [Abstract][Full Text] [Related]
7. Helminth infection enhances disease in a murine TH2 model of colitis. Hunter MM; Wang A; McKay DM Gastroenterology; 2007 Apr; 132(4):1320-30. PubMed ID: 17408663 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model. del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice. Wu W; Wang F; Gao X; Niu T; Zhu X; Yan X; Chen H BMC Gastroenterol; 2016 Mar; 16():41. PubMed ID: 27015810 [TBL] [Abstract][Full Text] [Related]
10. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice. Zhao J; Wang H; Shi P; Wang W; Sun Y Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475 [TBL] [Abstract][Full Text] [Related]
11. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083 [TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020 [TBL] [Abstract][Full Text] [Related]
13. The traditional herbal medicine saireito exerts its inhibitory effect on murine oxazolone-induced colitis via the induction of Th1-polarized immune responses in the mucosal immune system of the colon. Watanabe T; Yamamoto T; Yoshida M; Fujiwara K; Kageyama-Yahara N; Kuramoto H; Shimada Y; Kadowaki M Int Arch Allergy Immunol; 2010; 151(2):98-106. PubMed ID: 19752563 [TBL] [Abstract][Full Text] [Related]
15. Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis. Punit S; Dubé PE; Liu CY; Girish N; Washington MK; Polk DB Gastroenterology; 2015 Oct; 149(4):993-1005.e2. PubMed ID: 26072395 [TBL] [Abstract][Full Text] [Related]